Surgical Treatment of Neuroendocrine Liver Metastases

Table 2

Case series of hepatic resections with ablation performed for neuroendocrine liver metastases.

	Author	Year	N undergoing resection/ablation	Operative mortality (%)	Operative morbidity (%)	Symptom control (%)	Survival
(1)	Mayo et al. [39]	2010	339	NA	NA	NA	74% at 5 years
(2)	Glazer et al. [42]	2010	172	0	22.1	NA	77.4% at 5 years; 50.4% at 10 years
(3)	Strosberg et al. [108]	2009	31	NA	NA	NA	75% at 5 years; median survival of 103 months
(4)	Touzios et al. [27]	2005	19	5.2	42	95	72% at 5 years
(5)	Musunuru et al. [31]	2006	13	NA	NA	100	83% at 3 years

Some studies [22, 65, 102, 109] are excluded in the tables as the data is not stratified to liver resections and thus no meaningful data can be extracted for liver resections.